COMPASS Pathways plcCMPS

NASDAQHealthcareBiotechnology$6.39-3.62%

Developing psychedelic-based therapies for mental health disorders, the company is focused on psilocybin-assisted treatment for conditions such as treatment‑resistant depression. Its lead candidate, COMP360, is in late-stage clinical development and is being evaluated alongside psychological support...

Market Cap: $613.5M52W Range: $2.25 – $8.90

This page tracks all publicly disclosed congressional trades in COMPASS Pathways plc (CMPS), a company in the Healthcare sector. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.

Total Disclosures

Unique Politicians

Buys

Sells

Congressional Trading History

No congressional trades found for this stock.

All stocks traded by Congress Full trade feed Most active traders About the STOCK Act Report missing trade

COMPASS Pathways plcCMPS

Congressional Trading History

Related